Calpain III mutation analysis of a heterogeneous limb-girdle muscular dystrophy population

Neurology

Volumn 52, Issue 5, 1999, Pages 1015-1020

  Chou, F L ^f   Angelini, C ^f   Daentl, D ^a   Garcia, C ^b   Greco, C ^c   Hausmanowa Petrusewicz, I ^d   Fidzianska, A ^d   Wessel, H ^f   Hoffman, Eric P ^e  

^a SHRINERS HOSPITALS FOR CHILDREN NORTHERN CALIFORNIA   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN;

AMINO ACID SUBSTITUTION; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CLINICAL FEATURE; CONTROLLED STUDY; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MAJOR CLINICAL STUDY; MUSCLE BIOPSY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033596817     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.5.1015     Document Type: Article

References (32)

1. Arikawa E, Hofman EP, Kaido M, et al. The frequency of patients having dystrophin abnormalities in a limb-girdle patient population. Neurology 1991;41:1491-1496.
2. Koenig M, Hoffman EP, Bertelson CJ, et al. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and effected individuals. Cell 1987;50:509-517.
3. Rojas CV, Hoffman EP. Recent advances in dystrophin research. Curr Opin Neurobiol 1991;1:420-429.
4. Hoffman EP, Arahata K, Minetti C, et al. Dystrophinopathy in isolated cases of myopathy in females. Neurology 1992;42: 967-975.
5. Tome FMS, Evangelista T, Ieclerc A, et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci 1994;317: 351-357.
6. Pegoraro E, Mancias P, Swerdlow SH, et al. Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy. Ann Neurol 1996;40:782-791.
7. Duggan DJ, Gorospe JR, Fanin M, Hoffman EP. Mutations in the sarcoglycan genes in patients with myopathy. N Engl J Med 1997;336:618-624.
8. Hayashi YK, Chou F-L, Engvall E, et al. Mutations in the integrin alpha 7 gene cause congenital myopathy. Nat Genet 1998;19:94-97.
9. Ljunggren A, Duggan D, McNally E, et al. Primary adhalin deficiency as a cause of muscular dystrophy in patients with normal dystrophin. Ann Neurol 1996;38:367-372.
10. Bonneman CG, Modi R, Noguchi S, et al. Mutations in the dystrophin-associated glycoprotein β-sarcoglycan (A3b) cause autosomal recessive muscular dystrophy with disintegration of the sarcoglycan complex. Nat Genet 1995;11:266-273.
11. Noguchi S, McNally EM, Ben Othmane K, et al. Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy. Science 1995;270:819-822.
12. Nigro V, de sa Moreira E, Piluso G, et al. Autosomal recessive limb-girdle muscular dystrophy, LGMD 2F, is caused by a mutation in the δ-sarcoglycan gene. Nat Genet 1996;14:195-198.
13. Lui J, Aoki M, Illa I, et al. Dysferlin, a novel skeletal muscle gene is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998;20:31-36.
14. Bashir R, Britton S, Strachan T, et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 1998;20:37-42.
15. Beckmann JS, Richard I, Hillaire D, et al. A gene for limb-girdle muscular dystrophy maps to chromosome 15 by linkage. C R Acad Sci 1991;312:141-148.
16. Passos-Bueno MR, Richard I, Vainzof M, et al. Evidence of genetic heterogeneity in the autosomal recessive adult forms of limb-girdle muscular dystrophy following linkage analysis with 15q probes in Brazilian families. J Med Genet 1993;30: 385-387.
17. Richard I, Broux O, Allamand V, et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 1995;81:27-40.
18. Sorimachi H, Imajoh-Ohmi S, Emori Y, et al. Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m-and μ-types. J Biol Chem 1989;264:20106-20111.
19. Sorimachi H, Toyama-Sorimachi N, Saido T, et al. Muscle-specific calpain, p94, is degraded by autolysis immediately after translocation, resulting in disappearance from muscle. J Biol Chem 1993;268:10593-10605.
20. Saido TC, Sorimachi H, Suzuki K. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J 1994;8:814-822.
21. Glisin V, Crkvenjakov R, Byus C. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry 1974;13:2633-2637.
22. Wang J, Rojas CV, Zhou J, et al. Sequence and genomic structure of the human adult skeletal muscle sodium channel a subunit gene on 17q. Biochem Biophys Res Commun 1992; 182:794-801.
23. Orita M, Iwahana H, Kanazawa H, et al. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphism. Proc Natl Acad Sci USA 1989;86:2766-2770.
24. Richard I, Brenguier L, Dincer P, et al. Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographic origins. Am J Hum Genet 1997;60:1128-1138.
25. Fardeau M, Eymard B, Mignard C, et al. Chromosome 15-linked limb-girdle muscular dystrophy: clinical phenotypes in La Reunion Island and French metropolitan communities. Neuromuscul Disord 1996;6:447-453.
26. Dincer P, Leturcq F, Richard I, et al. A biochemical, genetic, and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey. Ann Neurol 1997;42:222-229.
27. Kawai H, Akaike M, Endo T, et al. An identical calpain 3 gene mutation in two separate families with limb-girdle muscular dystrophy (LGMD2A). Am J Hum Genet 1997;61(4S):A336. Abstract.
28. Topaloglu H, Dincer P, Richard I, et al. Calpain-3 deficiency causes a mild muscular dystrophy in childhood. Neuropediatrics 1997;28:212-216.
29. Sorimachi H, Kinbara K, Kimura S, et al. Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94 specific sequence. J Biol Chem 1995;270:31158-31162.
30. Kinbara K, Sorimachi H, Ishiura S, et al. Muscle specific calpain, p94, interacts with the extreme C-terminal region of connectin, a unique region flanked by two immunoglobulin C2 motifs. Arch Biochem Biophys 1997;342:99-107.
31. Fougerousse F, Durand M, Suel L, et al. Expression of genes (CAPN3, SGCA, SGCB, and TTN) involved in progressive muscular dystrophies during early human development. Genomics 1998;48:145-156.
32. Anderson L, Davison K, Moss J, et al. Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Am J Pathol 1998;153:1169-1179.